Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2015

Jul 13, 2015

32870_dirs_2015-07-13_ad445e27-9d97-41b2-9029-4446e3ddd607.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-07-13

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-07-13 Common Stock S 4922 $34 Disposed 18655 Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.